<DOC>
	<DOCNO>NCT01168414</DOCNO>
	<brief_summary>This single-center , cross-over comparison parallel group randomize trial design evaluate efficacy safety Ganfort compare Duotrav treatment period 8 week .</brief_summary>
	<brief_title>A Study Ganfort Versus Duotrav Patients With Primary Open Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Cloprostenol</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>1 . Visual acuity 6/60 good 2 . Patients control ( IOP &lt; 21 mmHg ) nonfixed combination Latanoprost &amp; Timolol least 3 month baseline visit 3 . Patients monotherapy either Latanoprost Timolol eligible dual therapy satisfactorily control ( IOP &gt; 21mmHG ) 1 . Angle closure glaucoma 2 . Neovascular Galucoma 3 . Secondary open angle glaucoma 4 . Ocular infection/inflammation within 3 month 5 . Ocular surgery within 3 month 6 . History Refractive surgery 7 . Argon laser trabeculoplasty/Selective laser trabeculoplasty 8 . Pregnancy/nursing 9 . Hypersensitivity benzalkonium chloride component trial drug solution . 10 . Patients betablockers contraindicate 11 . Patients drug know affect IOP .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>